Abstract:Atopic eczema/dermatitis syndrome is a term that covers different subtypes of atopic dermatitis. The "intrinsic" type of atopic dermatitis is non-IgE-associated, and the "extrinsic" type is IgE-associated atopic eczema/dermatitis syndrome. In the etiopathogenesis of atopic dermatitis there are well known interactions among genetic, environmental, skin barrier, immune factors, and stress. Genetic factors determine the expression of atopic dermatitis as pure or mixed with concomitant respiratory or intestinal allergy, depending on genetic susceptibility. Immunologic abnormalities of type I and type IV reactions have been described in patients with atopic dermatitis. Immunologic triggers are aeroallergens, food allergens, microbial products, autoallergens and contact allergens. Immune reactions determine many features of atopic dermatitis. These immune reactions also include cell mediated or delayed hypersensitivity. The currently accepted model proposes a predominant Th2 cytokine milieu in the initiating stages of acute atopic dermatitis lesions, and a mixed Th1 and Th2 pattern in chronic lesions. A two-phase model includes Th2 initiation with attraction of macrophages and eosinophils, which in turn produce interleukin 12 that is the activator of Th1 type response. Atopic dermatitis skin contains an increased number of IgE-bearing Langerhans cells which bind allergens via the high-affinity IgE receptor (FcepsilonRI). Langerhans cells play an important role in cutaneous allergen presentation to Th2 cells via major histocompatibility molecules. Eosinophilia and IgE production are influenced by type 2 cytokines. Degranulation of eosinophils occurs in the dermis with the release of toxic proteins such as major basic protein and could account for much of the inflammation. Mast cells are increased in number and produce mediators other than histamine that induce pruritus and may have an effect on interferon gamma expression. Mast cells produce a number of proinflammatory cytokines. There is an elevated production of prostaglandin E2 by peripheral monocytes. Prostaglandin E2 has at least two potential roles in the initiation of atopic dermatitis. Firstly, it reduces interferon-gamma production by T helper cells, thereby favoring the initial, dominant Th2 immune response; and secondly, it directly enhances IgE production by B lymphocytes with an increased secretion of interleukin 4, interleukin 5 and interleukin 13. Many lesions of atopic dermatitis result from scratching, thus it is tempting to speculate that immune perturbations in genetically predisposed individuals provoke the release of local pruritogens and keratinocyte-derived cytokines, which then further exacerbate the previously described immune response.

Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease

Exaggerated IL-17 Response to Epicutaneous Sensitization Mediates Airway Inflammation in the Absence of IL-4 and IL-13.

The extracellular serine protease from Staphylococcus epidermidis elicits a type 2-biased immune response in atopic dermatitis patients

Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin

Staphylococcus aureus second immunoglobulin-binding protein drives atopic dermatitis via IL-33

Epicutaneous Antigen Exposure Induces A Th17 Response That Drives Airway Inflammation After Inhalation Challenge

Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients

Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented?

Role of mast cells in Staphylococcus aureus enterotoxin B-induced atopic dermatitis-like skin inflammation in mice

Association between specific IgE to staphylococcal enterotoxin B and the eosinophilic phenotype of asthma

A therapeutic strategy to target distinct sources of IgE and durably reverse allergy

Prostaglandins E2 Signal Mediated by Receptor Subtype EP2 Promotes IgE Production in Vivo and Contributes to Asthma Development.

Epicutaneous Sensitization with Ovalbumin, Staphylococcal Enterotoxin B and Vitamin D Analogue Induces Atopic Dermatitis in Mice.

Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis

Staphylococcus aureus δ-toxin present on skin promotes the development of food allergy in a murine model

Etiopathogenesis of atopic dermatitis--an overview

Eosinophil-derived Leukotriene C4 Signals Via Type 2 Cysteinyl Leukotriene Receptor to Promote Skin Fibrosis in a Mouse Model of Atopic Dermatitis.

The Riddle of Response to Cutaneous Allergen Exposure in Patients with Atopic Dermatitis

IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases

Allergen-induced Expression Of Il-25 And Il-25 Receptor In Asthmatic Airways And In Allergen-induced Late Phase Cutaneous Responses In Atopic Subjects

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice